2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。出版社推荐: | 热 美国化学会ACS期刊一览 | 新 IF 2.9,JCR Q2 神经系统基础研究期刊征稿中 | 新 开放获取选刊时如何避雷?点击查看干货指南! |
基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Vaccines VACCINES-BASEL (此期刊被最新的JCR期刊SCIE收录) LetPub评分 7.3
56人评分
我要评分
声誉 8.2 影响力 6.0 速度 9.6 | |||||||||||||||||||||||||||||||||
期刊ISSN | 2076-393X | 微信扫码收藏此期刊 | ||||||||||||||||||||||||||||||||
2023-2024最新影响因子 (数据来源于搜索引擎) | 5.2 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||||
实时影响因子 | 截止2024年10月29日:2.502 | |||||||||||||||||||||||||||||||||
2023-2024自引率 | 17.30%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||||
五年影响因子 | 4.9 | |||||||||||||||||||||||||||||||||
JCI期刊引文指标 | 1.23 | |||||||||||||||||||||||||||||||||
h-index | 暂无h-index数据 | |||||||||||||||||||||||||||||||||
CiteScore ( 2024年最新版) |
| |||||||||||||||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||||||||||||||
期刊官方网站 | https://www.mdpi.com/journal/vaccines | |||||||||||||||||||||||||||||||||
期刊投稿网址 | https://login.mdpi.com/login?_target_path=https%3A%2F%2Fsusy.mdpi.com%2Fuser%2Flogin%3FauthAll%3Dtrue | |||||||||||||||||||||||||||||||||
期刊语言要求 | Language To facilitate proper peer-reviewing of your manuscript, it is essential that it is submitted in grammatically correct English. MDPI provides minor English editing by native English speakers for all accepted papers, included in the APC. The APC does not cover extensive English editing. Your paper could be returned to you at the English editing stage of the publication process if extensive editing is required. You may choose to use a paid language-editing service before submitting your paper for publication. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Vaccines的语言要求,还能让Vaccines编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Vaccines编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||||||||||
是否OA开放访问 | Yes | |||||||||||||||||||||||||||||||||
OA期刊相关信息 | 文章处理费:需要( CHF2700; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:immunopathogenesis、vaccines 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||||||||||||||
通讯方式 | ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052 | |||||||||||||||||||||||||||||||||
出版商 | MDPI (Basel, Switzerland) | |||||||||||||||||||||||||||||||||
涉及的研究方向 | Pharmacology, Toxicology and Pharmaceutics-Pharmacology | |||||||||||||||||||||||||||||||||
出版国家或地区 | Switzerland | |||||||||||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||||||||||
出版周期 | ||||||||||||||||||||||||||||||||||
出版年份 | 2013 | |||||||||||||||||||||||||||||||||
年文章数 | 1803点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||||
Gold OA文章占比 | 99.61% | |||||||||||||||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 80.37% | |||||||||||||||||||||||||||||||||
WOS期刊SCI分区 ( 2023-2024年最新版) | WOS分区等级:1区
| |||||||||||||||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:预警等级:低 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2023年12月最新升级版) | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2022年12月升级版) |
| |||||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2021年12月旧的升级版) |
| |||||||||||||||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2076-393X%5BISSN%5D | |||||||||||||||||||||||||||||||||
平均审稿速度 | 期刊官网数据: 平均18.06天 网友分享经验: 11 Weeks | |||||||||||||||||||||||||||||||||
平均录用比例 | 网友分享经验: | |||||||||||||||||||||||||||||||||
版面费/APC文章处理费信息 | 文章处理费:需要( CHF2700; ) 文章处理费豁免:查看说明 其他费用:没有 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Vaccines顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||||||||||||||||||
期刊常用信息链接 |
|
|
中国学者近期发表的论文 | |
1. | Efficacy and Safety of COVID-19 Vaccination in Older Adults: A Systematic Review and Meta-Analysis Author: Zhang, Lei; Jiang, Lihong; Tian, Tian; Li, Wenjing; Pan, Yonghui; Wang, Yongchen Journal: VACCINES. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.3390/vaccines11010033 PubMed DOI |
2. | Changes in COVID-19 Vaccine Acceptability among Parents with Children Aged 6-35 Months in China-Repeated Cross-Sectional Surveys in 2020 and 2021 Author: Zhang, Kechun; Liang, Xue; Tam, Karen Lau Wa; Kawuki, Joseph; Chan, Paul Shing-fong; Chen, Siyu; Fang, Yuan; Cao, He; Zhou, Xiaofeng; Chen, Yaqi; Hu, Tian; Chen, Hongbiao; Wang, Zixin Journal: VACCINES. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.3390/vaccines11010170 PubMed DOI |
3. | Development and Validation of the Outcome Expectancy Scale for COVID-19 Vaccination in the Adult General Population Author: Yu, Yanqiu; Fong, Vivian W. I.; Lau, Mason M. C.; Lau, Joseph T. F. Journal: VACCINES. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.3390/vaccines11010085 PubMed DOI |
4. | Anti-SARS-CoV-2 IgM Secondary Response Was Suppressed by Preexisting Immunity in Vaccinees: A Prospective, Longitudinal Cohort Study over 456 Days Author: Xu, Qiu-Yan; Xie, Lin; Zheng, Xin-Qi; Liang, Xian-Ming; Jia, Zhi-Juan; Liu, Yan-Yun; Liang, Xiao-Yu; Liu, Li-Li; Yang, Tian-Ci; Lin, Li-Rong Journal: VACCINES. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.3390/vaccines11010188 PubMed DOI |
5. | Strategies for Prevention and Control of Vibriosis in Asian Fish Culture Author: Xu, Kangping; Wang, Yushu; Yang, Wangxiaohan; Cai, Hongyan; Zhang, Youyu; Huang, Lixing Journal: VACCINES. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.3390/vaccines11010098 PubMed DOI |
6. | Acceptance and Preference for COVID-19 Vaccine among Japanese Residents at Early Stage of the Epidemic in Japan Author: Wu, Jiwen; Cai, Guoxi; Fan, Yi; Arima, Kazuhiko; Lin, Yulan; Wong, Liping; Zhang, Zhuo; Yamamoto, Taro; Morita, Kouichi; Yoshikawa, Akira; Lu, Yixiao; Aoyagi, Kiyoshi Journal: VACCINES. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.3390/vaccines11010157 PubMed DOI |
7. | Oral Vaccination of Recombinant Saccharomyces cerevisiae Expressing ORF132 Induces Protective Immunity against Cyprinid Herpesvirus-2 Author: Wang, Licong; Yang, Maoxia; Luo, Sheng; Yang, Guanjun; Lu, Xinjiang; Lu, Jianfei; Chen, Jiong Journal: VACCINES. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.3390/vaccines11010186 PubMed DOI |
8. | S Trimer Derived from SARS-CoV-2 B.1.351 and B.1.618 Induced Effective Immune Response against Multiple SARS-CoV-2 Variants Author: Wang, Hongye; Wang, Zengshuai; Ma, Liang; Zhu, Xiaoyong; Li, Bingxiang; Huang, Yuhang; Li, Jingwen; Sun, Ming; Shi, Li; Yao, Yufeng Journal: VACCINES. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.3390/vaccines11010193 PubMed DOI |
9. | Safety, Efficacy, and Immunogenicity of Varying Types of COVID-19 Vaccines in Children Younger Than 18 Years: An Update of Systematic Review and Meta-Analysis Author: Tian, Yan; Chen, Long; Shi, Yuan Journal: VACCINES. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.3390/vaccines11010087 PubMed DOI |
10. | Comorbid Asthma Increased the Risk for COVID-19 Mortality in Asia: A Meta-Analysis Author: Shi, Liqin; Ren, Jiahao; Wang, Yujia; Feng, Huifen; Liu, Fang; Yang, Haiyan Journal: VACCINES. 2023; Vol. 11, Issue 1, pp. -. DOI: 10.3390/vaccines11010089 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室